Best MRI of one area gastroenterologists in Spain: TOP 30 doctors

Professional experience

• 2018 – present : Head of the Traumatology Department at the International Orthopaedic Center Hospital Ruber Internacional in Madrid.
• 2000 – 2018 : Specialist in Hip and Knee Surgery at the International Center Hospital Ruber Internacional, Madrid.
• Until 2000 : Deputy Head of the Traumatology Department at the Hospital J. Puerta de Hierro, Madrid.

Education and qualifications

• 1992 : Medical degree from the Faculty of Medicine and Surgery of the Autonomous University of Madrid.
• Specialization in Orthopedic Surgery and Traumatology at the Puerta de Hierro Hospital.

Scientific research and clinical trials

1. Phase 2B : Efficacy and safety study of PD 0348292 for the prevention of venous thromboembolic events (VTE) in patients undergoing total knee arthroplasty.
2. CV185-047 : Comparison of the efficacy of apixaban and enoxaparin for the prevention of VTE.
3. CV185-035 : A study of prevention of deep vein thrombosis after hip replacement.
4. PRADAXA® 1160.85 : A study of the efficacy of dabigatran etexilate for the prevention of VTE following hip and knee surgery.
5. PRADAXA® 1160.84 : Evaluation of the safety of dabigatran in patients with moderate renal impairment after total renal arthroplasty.

Learning and Teaching

• 1997–2000 : Associate Professor, Department of Traumatology, Puerta de Hierro Hospital, Madrid.

Specialization and innovation

• Knee replacement : Using the latest generation navigation sys, Rapid Recovery and ERAS protocols for accelerated recovery.
• Hip Replacement : Minimally Invasive Techniques and Improved Restorative Protocols.
• Arthroscopic surgery : Treatment of diseases of the knee and hip joints.
• Non-surgical treatment : Introduction of innovative infiltration techniques for joint pathology.

Recognition and achievements

• 2022 : Included in the Forbes list as one of the 100 best doctors in Spain , recognized for leadership and innovation in joint surgery using navigation technologies.
• Since 2008 : ISO 9001:2008 certification for quality of hip and knee replacement surgeries.

Membership in professional organizations

• International Member of the American Academy of Orthopaedic Surgeons .
• Member of the Spanish Association of Arthroscopy .

The doctor has established himself as a pioneer in the field of joint surgery, introducing innovative technologies such as navigation sys and minimally invasive approaches. His achievements and approach to patient recovery make him one of the leading specialists in Spain.

Since 1998 he has been Director of the Epilepsy Unit at the Ruber International Hospital in Madrid, a pioneering centre for the diagnosis, medical and surgical treatment of epilepsy in children and adults.

More than 150 neurologists and neurophysiologists from Spain and Latin America have been trained here, and several of its students have successfully opened epilepsy centres in other public and private hospitals, both in Spain and abroad.

The program he directs has become a pioneer in Spain in the field of genetic diagnosis of complex epilepsies and advanced treatments such as drug repositioning, interstitial laser treatment, deep electrodes and gamma radiosurgery, which are used in patients with refractory epilepsy.

Dr. Antonio Gil-Nagel is a professor at the IE University, is an Ad Honorem Professor at the Center for Biomedical Technology of the Polytechnic University of Madrid (CTB) and is Director of the Epilepsy Department at the Francisco Vitoria University of Madrid.

He was a founding member of the European Epilepsy Research Network and the European Association for Epilepsy Monitoring. He is also active in international research projects such as EpiCare and the European Epilepsy Brain Bank and has held relevant positions in international institutions such as the International Bureau for Epilepsy (IBE), the International League Against Epilepsy (ILAE), the European Federation of Neurological Societies (EFNS) and the World Federation of Neurology (WFN).

Dr. Gil-Nagel has directed numerous clinical trials and research studies in the field of epilepsy, especially in orphan epilepsies such as Dravet syndrome, Lennox-Gastaut syndrome and other epileptic and developmental encephalopathies. The Epilepsy Program he directs is an international benchmark in the development of pharmacological research. He has been the Principal Investigator of phase II and III clinical trials, including numerous clinical trials and non-pharmacological treatments (epilepsy surgery, electrical stimulation, ketogenic diet and gamma knife). His research is funded by European Union funds and the Public Innovation Agency of the Ministry of Science and Innovation of the Spanish Government. Their dedication to research and the development of new treatments allows them to accelerate the treatment of their patients with new treatments.

In addition to being a frequent speaker at national and international conferences, he has authored several books on epilepsy and electroencephalography and has numerous publications on epilepsy in journals such as Annals of Neurology, Brain, Epilepsy, European Journal of Neurology, Journal of Neurology, Nature Neurology, Neurology, and the New England Journal of Medicine, among others. He has authored 165 Scopus-indexed articles with 5,265 citations and an h-index of 35.

In 2021, his team received the Innovative Small and Medium Enterprise Award for the project on mesial temporal lobe epilepsy and encephalocele (Ministry of Science and Innovation, Spain), and in 2012, the Scientific Award from the Epilepsy Group of the Spanish Society of Neurology (SEN).

Education

• 1985 – Bachelor of Medicine and Surgery , Complutense University of Madrid.
• 1986-1989 – Specialization in Neurology , Hospital 12 de Octubre, Madrid.
• 1991–1993 – Epilepsy Specialist , Comprehensive Epilepsy Program, University of Minnesota, Minneapolis, USA.
• 1997 – Certification of the American Board of Clinical Neurophysiology .

Professional experience

• 1993–1995 – Associate Professor, Epilepsy Program, Department of Neurology, University of Minnesota, Minneapolis, USA.
• 1995–1998 – Associate Professor, Epilepsy Program, Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, USA.
• Since 1998 – Director of the Epilepsy Program , Neurology Service, Ruber International Hospital, Madrid.
• 2014 – Defense of the dissertation on the topic: "Clinical and neurophysiological studies in the pre-surgical evaluation of epilepsy" , Complutense University of Madrid.
• 2022 – Deputy Head of the Neurology Service , Ruber Internacional International Hospital, Madrid.

Membership in professional societies

• Since 1991 – Member of the American Academy of Neurology (AAN).
• Since 1991 – Member of the American Epilepsy Society (AES).
• Since 1996 – Member of the American Society of Clinical Neurophysiology .
• Since 1988 – Member of the Spanish Society of Neurology .
• Since 2006 – Representative of Spain in the World Federation of Neurology (WFN).
• Since 2006 – Member of the editorial committee and the WFN web portal .
• Since 2008 – Director of the Epilepsy Group of the European Federation of Neurological Societies (EFNS).
• Since 2009 – Member of the EFNS Educational Courses Committee.
• 2007–2009 – Member of the EFNS Scientific Committee .
• 2007–2008 – Vice-President of the Scientific Committee of the 12th EFNS Congress , Madrid.
• 2004–2007 – Delegate of Spain to the EFNS .
• 2009 – Member of the Scientific Committee of the World Congress of Neurologists , Marrakech.

Outstanding Achievements

Dr. Hill-Nagel is a leading international figure in the field of epileptology, a recognized expert in the diagnosis and treatment of genetic epilepsy and the surgical approach to its correction. His distinguished professional career includes many years of experience in leading medical institutions in the United States and Europe, as well as active participation in international research and educational programs.

Dr. Hill-Nagel not only advances the science of neurology on a global level, but also successfully implements cutting-edge treatment methods, improving the lives of thousands of patients around the world.

 CURRICULUM VITAE. José E. Batista-Miranda PhD MD  Jan 2025 

Correspondence (Uroclinica Center) : Via Augusta 158. Barcelona, Spain               

Hospital: Centro Medico Teknon/ Grupo Quironsalud,  Vilana 12. 08021  Barcelona, Spain. 

Phone: 34- 687  99 54 57

Qualification: Qualfied urologist in Spain and UK (GMC specialist list) 

Current position.  Urodynamics Head and Consultant Urologist, CM Teknon, Barcelona, since 1996

                                    Director, Uroclinica Team and Continentia Association ( continentia.org)

                                    Co- director: Functional Urology program UAX University, Madridr     

Previous professional Experience

2005- Senior Clinical Chief in Urodynamics. Hospital Vall d´Hebron. Barcelona. 

1995-2003 Consultant Urologist. Urodynamics and Oncology Units. F. Puigvert, Barcelona.

1994 Fellow in Neuro-Urology. Boston University (Drs. Krane & Siroky) and Harvard´s Children´s Hospital (Dr. Bauer) Boston, USA (La Caixa grant).

1994- Registrar. Bristol Urological Institute,U.K.(Mr. Abrams) (Research Council grant)

Current Professional Practice: experience

Head of Urodynamics: on line reporting of over 2000 studies / year at 5 different locations. 

General urology and functional urology clinic. 

Surgery:

1. Thulim and green-light laser vaporization (first case in Barcelona in 2003) .
2. Holmium enucleation (HOLEP)
3. HIFU focal treatment and MRI fusion biopsies
4. Ambulatory flexible cystoscopy
5. Fistula and incontinece surgery: vesico-vaginal fistula, TVT, bladder augmentation
6. Female urethral surgery: diverticula, para- urethral cysts.
7. Ureteroscopy and laser surgery for stones
8. General pediatric urologic surgery: scrotal and  preputial surgery

Urological and post-graduate training.

1997- PhD Thesis, Aut. Univ. of Barcelona (“Oxybutinin in children”) (Spanish Urol. Ass. Prize)

1994- Certified Urologist (Ministries of Health & Education)

1991-Urology Dept,USC Hospital, Los Angeles, CA.(Dr.Skinner) (Research Council grant)

1989-93- Residency in Urology. Fundacio Puigvert-National MIR program. (Dr. Solé Balcells).

Medical Education 

1981-87-Medical Degree, Universidad Autonoma de Barcelona (UAB). 1st Class Degree.

1985 & 86- Intern. Department of Surgery. Keiserin Elisabeth Spital, Viena, Austria.

1988-ECFMG Certificate (Permannent validation:February 1994)

Publications  

103 papers in journals: including 25 in international Journals (see annex)

Editor of 2 books on clinical cases in Urodynamics. 

Chapters in 4 books.

Co-editor "Impact Spanish Urology"

Translations for Br J Surgery, Advances in Urology, WHO/ICUD consultations . 

Presentations at congresses

45, including 28 at international congresses (Eur. Ass. Urol, Am Urol Ass, ICS, SIU, see annex).

Post-graduate teaching ( President, “Continentia association” www.continentia.org ) 

23 ICS accredited courses on Urodynamics  ( 5 English editions for Crotatia, Slonvenia, Hugary, Romania and Bulgaria) 

9 CME international/ multi specialty study days on functional urology and urogynechology 

Courses and talks at ICS and European Ass. meetings. 

Pre-graduate teaching

2010- Bladder dysfunction module. Faculty of Medicine, Aut. Univ of Barcelona

1990-92 Director: Basic Medical English Course for students. Autonomous Univ. of Barcelona.

1992-93 Clinical tutor in Urology (including seminars) Autonomous Univ. of Barcelona .

Invited / elected committee membership and  post graduate lecturer

WHO´s International Consultation on BPH (1995, 97, 2000)

WHO´s  International Consultation on Incontinence (1999, 2001)

Member, Ethics Committee, BarcelonaMedical College.

Secretary, Institutional Review Board (Ethics Research committee. F. Puigvert)

Clinical tutor ellected by Urology residents.

Invited speaker  in courses / symposiums in Spain, Mexico, Morocco and Italy.

Research projects / IRB approved trials / advisor. 

1993- IPSS validation in Spanish

1994- Epristeride phase III clinical trial (Boston University)

1994- Bladder blood flow evaluation (Boston University)

1995- Cavidox (Quality of life in BPH patients, Almirall Laboratories)

1996- Tamsulosin phase IV clinical trial (Boehringer Laboratories)

1996- Vesica international surgical study (Boston scientific) 

1997- European endourology panel (Boston scientific)

1997- YM 905, phase II clinical trial (Yamanouchi/ Astellas)

1998- present: Detrusor morphometry in obstruction (PhD thesis co-director)

2000- European panel on appropriate management on BPH (Erasmus University)

2001- Quality of life in radical prostatectomy vs brachytherapy. Use of FACT questionnaire.

2004- Effect of Aclidinium in  Urology  ( Almirall laboratories) 

2008- 2015: Nocturia Study ( Astellas Europe)

2012- “Beyond” ( Astellas Multicenter study on Mirabegron) Principal Investigator

2014- Belive ( Astellas post- commercialization study) 

2015- VHEA ( Hiperactive bladder in aging population, multicenter group; Principal investigator)

2019- Flow taker monitorization for nocturia ( Astellas grant)

2022- Idorsia Phase 3 nocturia study

2024- 3 researcher led studies: Ambulatory urodynamics register, Virtual reality, Tensi for overactive blader. 

WHO´s International Consultation on BPH (1995, 97, 2000)

WHO´s International Consultation on incontinence (1999, 2001)

MEMBERSHIP. Spanish Urol.Ass, ICS.

He completed two fellowships in spinal surgery, one in Aarhus, Denmark, with the support of the SICOT international society in 2012 and the second in complex spine surgery in Uppsala, Sweden, in 2016, with the support of a grant from the international society AOspine .

During his career, Dr. Covaro has a continuous participation in international meetings and contributed to several articles published in scientific magazines.

He has a great experience in the treatment of patients and uses the knowledge he has acquired to provide each patient with the best quality of care.

Dr. Covaro is a member of several professional organizations, including the Spanish Society of Orthopedics, AOspine, GEER and Eurospine.

During his career, Dr. Covaro has a continuous participation in international meetings and contributed to several articles published in scientific magazines. Dr. Covaro is a member of several professional organizations, including the Spanish Society of Orthopedics, AOspine, GEER and Eurospine.

Currently, Dr. Covaro attends his patients at the Institut Universitari Dexeus and the Hospital Universitari de Bellvitge, in Barcelona. To make an appointment with Dr. Augusto Covaro, contact ICATME, Institut Universitari Dexeus

Dr. Rodrigo Rocamora Zuniga is a neurologist who specializes in epilepsy. He leads the epilepsy department at HM Delfos Hospital in Spain. He is also a professor at UPF University. Dr. Rocamora earned his PhD from Bonn University in 2001. He completed his neurology training at Pontificia Universidad Católica de Chile and received his medical degree in Mendoza, Argentina.

Dr. Rocamora is accredited by the European Reference Network. He is an active member of SEN, CSUR, and EPI-Care. He has published over 100 scientific articles on drug-resistant epilepsy, epilepsy surgery, and cognitive impairment. His work has helped develop new protocols that have improved care for epilepsy patients.

Dr. Francisco Soldado is a family medicine specialist at Hospital HM Nou Delfos. He provides care for patients of all ages and is accredited in family medicine. Dr. Soldado uses the latest medical technologies in his practice.

He is known for his compassionate care and focus on patients’ needs. Dr. Soldado has a strong record of patient satisfaction and positive clinical results. He stays current in his field through ongoing medical education.

Dr. Fernando Villagrá is a respected cardiovascular surgeon who specializes in pediatric cardiac surgery. He completed his medical degree at the Complutense University of Madrid. He later earned his specialization in Cardiovascular Surgery at the Autonomous University of Madrid. His doctoral thesis received the distinction of “Outstanding Cum Laude.”

Dr. Villagrá has more than 40 years of experience. He has led pediatric cardiac surgery departments at top hospitals in Spain, including Hospital Universitario La Paz and Montepríncipe University Hospital. He has performed thousands of complex surgeries. He has also contributed to over 100 scientific publications in both international and national journals.

He is a member of the Spanish Society of Cardiology. He also serves on the editorial boards of leading medical journals. This reflects his dedication to advancing cardiovascular medicine.

Dr. López-Ibor is a specialist in Pediatric Hematology and Oncology. She earned her medical degree from the Complutense University of Madrid and her doctorate from the University of Barcelona. She is also accredited by the University of Maryland. Dr. López-Ibor treats bone and brain tumors, leukemia, and blood disorders.

She has over 20 years of experience. Dr. López-Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital. She has written many scientific articles, both nationally and internationally, and has made important contributions to her field.

Dr. Antonio Cubillo Gracián is a specialist in Medical Oncology. He has broad teaching and clinical experience at USP CEU and HM CIOCC. He has directed postgraduate research as Director of the Master’s in Clinical and Applied Research in Oncology. Since 2009, he has tutored more than 100 students, residents, and rotating staff.

Dr. Cubillo has advanced oncology education by teaching subjects such as General Medical Pathology, Oncology, Bioethics, and Pathophysiology. He has organized international courses on digestive neoplasms. He has also worked with leading institutions, including MD Anderson Cancer Center. His academic leadership and clinical mentorship have set high standards in oncology training and research.